Published in Anesthesiology on December 01, 1996
The bispectral index declines during neuromuscular block in fully awake persons. Anesth Analg (2003) 4.53
A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years. J Allergy Clin Immunol (1989) 3.08
Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J (2001) 2.52
Comparison of near-infrared spectroscopy and somatosensory evoked potentials for the detection of cerebral ischemia during carotid endarterectomy. Stroke (1998) 2.18
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations. J Rheumatol (1995) 2.09
COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J (2001) 1.97
Population pharmacokinetics of propofol: a multicenter study. Anesthesiology (2000) 1.90
Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med (1998) 1.75
Lumbar strengthening in chronic low back pain patients. Physiologic and psychological benefits. Spine (Phila Pa 1976) (1993) 1.72
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy (2006) 1.64
Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth (1989) 1.56
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth (1985) 1.42
Indwelling temporary retrobulbar catheter for long-lasting titratable local anesthesia. Arch Ophthalmol (2000) 1.39
Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet (1999) 1.32
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth (2012) 1.23
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J (2001) 1.18
Sympathetic blockade by epidural anesthesia attenuates the cardiovascular response to severe hypoxemia. Anesthesiology (1990) 1.15
Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol (2007) 1.14
Precision and accuracy of a new device (CNAPTM) for continuous non-invasive arterial pressure monitoring: assessment during general anaesthesia. Br J Anaesth (2010) 1.12
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost (2011) 1.11
Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience (2004) 1.10
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10
The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther (1999) 1.08
Microspectrophotometry of single rhabdomeres in the insect eye. Exp Cell Res (1966) 1.08
Tissue reactions under piezoelectric shockwave application for the fragmentation of biliary calculi. Gut (1989) 1.06
One-year survival after out-of-hospital cardiac arrest in Bonn city: outcome report according to the 'Utstein style'. Resuscitation (1997) 1.05
A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology (2001) 1.03
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02
The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Anesthesiology (2001) 1.02
Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. Br J Anaesth (1979) 1.02
Lung mechanics in antigen-induced asthma. J Appl Physiol (1974) 1.02
Retracted Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats. Eur J Anaesthesiol (2003) 1.02
Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. J Clin Pharmacol (1992) 1.02
Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01
Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J Biol Chem (2001) 1.01
Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem (2001) 1.00
Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00
Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia (1991) 0.99
Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain (1995) 0.98
Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther (2007) 0.97
Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine. Clin Pharmacol Ther (2001) 0.96
Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study. Br J Anaesth (2011) 0.96
Dose-related effects of ibuprofen on pain-related potentials. Br J Clin Pharmacol (1994) 0.96
Release of algesic substances in human experimental muscle pain. Inflamm Res (2002) 0.95
Modulation of spinal nociceptive processing through the glutamate transporter GLT-1. Neuroscience (2003) 0.94
Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration. Clin Pharmacol Ther (1999) 0.94
Peripheral antihyperalgesic effect of morphine to heat, but not mechanical, stimulation in healthy volunteers after ultraviolet-B irradiation. Anesth Analg (1999) 0.93
Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. Pharmacogenomics J (2006) 0.93
Procalcitonin--influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem (1997) 0.92
The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain. Clin Pharmacol Ther (2008) 0.92
Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport (1997) 0.92
Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J (2000) 0.92
Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Br J Anaesth (2008) 0.91
The superficial cervical plexus block for postoperative pain therapy in carotid artery surgery. A prospective randomised controlled trial. Eur J Vasc Endovasc Surg (2006) 0.91
Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain (2001) 0.91
Changes in pulmonary function in Parkinson's syndrome after treatment with L-DOPA. Am Rev Respir Dis (1971) 0.91
Cytotoxicity of dental alloy extracts and corresponding metal salt solutions. J Dent Res (1998) 0.90
Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett (1998) 0.90
Equipment for pre-hospital airway management on Helicopter Emergency Medical System helicopters in central Europe. Acta Anaesthesiol Scand (2011) 0.90
Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth (2011) 0.90
Pharmacokinetics and pharmacodynamics of GPI 15715 or fospropofol (Aquavan injection) - a water-soluble propofol prodrug. Handb Exp Pharmacol (2008) 0.90
Fragmentation of biliary calculi by means of extracorporeally generated piezoelectric shock waves. Dig Dis Sci (1989) 0.89
Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration. Clin Pharmacol Ther (1998) 0.89
Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89
Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration. Antimicrob Agents Chemother (1997) 0.89
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther (2009) 0.88
EEG-controlled closed-loop dosing of propofol in rats. Br J Anaesth (2004) 0.88
Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers. Anesthesiology (1999) 0.88
Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation. Neurosci Lett (2000) 0.88
Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology (1999) 0.88
Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol (1997) 0.88
Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet (2001) 0.88
Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia. Inflamm Res (2001) 0.88
Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen. Mol Pharmacol (1997) 0.88
Comparison of tissue concentrations after intramuscular and topical administration of ketoprofen. Pharm Res (2001) 0.87
Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block. Br J Pharmacol (2014) 0.87
Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology (1987) 0.87
Differential effects of dipyrone, ibuprofen, and paracetamol on experimentally induced pain in man. Agents Actions (1992) 0.87
Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology (1997) 0.87
[Patient-controlled analgesia (PCA) in outpatients with cancer pain. Analysis of 1,692 treatment days]. Schmerz (2007) 0.86
Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients. Postgrad Med J (1985) 0.86
Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column. J Chromatogr (1990) 0.86
Sodium cromoglycate (intal) in the treatment of vernal keratoconjunctivitis and allergic conjunctivitis. Can J Ophthalmol (1976) 0.86
Variability of inversion of (R)-flurbiprofen in different species. J Pharm Sci (1992) 0.86
[Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery]. Anasthesiol Intensivmed Notfallmed Schmerzther (1995) 0.86
[Predictability and precision of "target-controlled infusion" (TCI) of propofol with the "Disoprifusor TCI" system]. Anaesthesist (1998) 0.85
5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Br J Pharmacol (2010) 0.85